Metabolomics analysis identifies differential metabolites and potential diagnostic biomarkers among pediatric sepsis subtypes
PLOS One · 11.06.2026 · 21 (6) · e0351295
DOI: 10.1371/journal.pone.0351295 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 11.06.2026. Verfasst von Sisi Zhuang und 1 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Biomarkers, Sepsis, Metabolomics, Metabolome. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Hospital(the First Affiliated Hospital with Nanjing Medical University)Clinical Capacity Enhancement Project.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis in children can be caused by a variety of pathogens, with bacteria and viruses being the most common. This study used metabolomics to identify differences in metabolic profiles and potential biomarkers among pathogens causing pediatric sepsis.
Methods
Serum metabolomic profiles of pediatric bacterial and viral sepsis were obtained from the MetaboLights database (MTBLS563). Principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and orthogonal PLS-DA were employed to explore metabolic distinctions. Differential expression metabolites (DEMs) were identified using the Wilcoxon rank-sum test and variable importance in projection (VIP) scores. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, receiver operating characteristic (ROC) analysis, Extreme Gradient Boosting (XGBoost) modeling, and Shapley Additive exPlanations (SHAP) analysis were conducted to determine diagnostic metabolites and evaluate model performance.
Results
PCA and PLS-DA revealed distinct metabolic profiles among bacterial pediatric sepsis (PBID_PS), viral pediatric sepsis (VID_PS), and healthy controls. Fourteen differential metabolites were identified, primarily enriched in nitrogen metabolism, arginine biosynthesis, and the metabolism of alanine, aspartate, and glutamate. Among them, choline, glutamate, and glutamine exhibited strong discriminatory ability between PBID_PS and VID_PS. XGBoost and SHAP analyses confirmed these metabolites as key diagnostic indicators, achieving excellent predictive performance and revealing distinct metabolic reprogramming underlying different etiologies of pediatric sepsis.
Conclusion
Metabolomic profiling revealed distinct metabolic signatures between bacterial and viral pediatric sepsis, with glutamate, glutamine, and choline serving as potential biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Sisi Zhuang
Förderung
- Jiangsu Province Hospital(the First Affiliated Hospital with Nanjing Medical University)Clinical Capacity Enhancement Project
Zitieren
APA
Zhuang, S., & Zuo, L. (2026). Metabolomics analysis identifies differential metabolites and potential diagnostic biomarkers among pediatric sepsis subtypes. PLOS One, 21(6), e0351295. https://doi.org/10.1371/journal.pone.0351295
Vancouver
Zhuang S, Zuo L. Metabolomics analysis identifies differential metabolites and potential diagnostic biomarkers among pediatric sepsis subtypes. PLOS One. 2026;21(6):e0351295. doi:10.1371/journal.pone.0351295
BibTeX
@article{Zhuang2026,
author = {Zhuang, Sisi and Zuo, Lili},
title = {Metabolomics analysis identifies differential metabolites and potential diagnostic biomarkers among pediatric sepsis subtypes},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0351295},
doi = {10.1371/journal.pone.0351295}
}
EUVIMED